12.37  -1.65 (-11.77%)		09-18 16:00
Open: 15.15 High: 15.15 Volume: 5,666,926		Pre. Close: 14.02 Low: 12.1 Market Cap: 767(M)

Short term
Mid term
Targets	6-month :	15.89	1-year :	17.69
Resists	First :	13.6	Second :	15.14
Pivot price	12.66
Supports	First :	11.1	Second :	9.24
MAs	MA(5) :	13.31	MA(20) :	12.82
	MA(100) :	7.78	MA(250) :	6.89
MACD	MACD :	0.7	Signal :	0.8
%K %D	K(14,3) :	65.6	D(3) :	70.5
RSI	RSI(14): 51.3
52-week	High :	15.14	Low :	3.75

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HELP ] has closed above bottom band by 40.3%. Bollinger Bands are 20.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	15.17 - 15.25	15.25 - 15.32
Low:	11.95 - 12.02	12.02 - 12.08
Close:	12.25 - 12.37	12.37 - 12.48

Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.

Fri, 11 Sep 2026
CYBIN INC. Executive Chair So Eric H. L. Acquires 100,000 Shares at $12.39 Each - Kalkine Media

Thu, 10 Sep 2026
CYBIN INC. (NASDAQ: HELP) Executive Eric So Holds Sole Authority Over 4.37 Million Shares - Kalkine Media

Wed, 09 Sep 2026
Executive chair buys 95,000 Cybin (HELP) shares in latest stake filing - Stock Titan

Wed, 09 Sep 2026
Cybin (HELP) growth chief buys 90,000 shares in $1.04M trade - Stock Titan

Wed, 09 Sep 2026
Eric H. L. So Discloses Investment at Cybin Inc. with 5.8% Stake - TradingView

Tue, 18 Aug 2026
CRACU Holds Steady at $10.25 as Crown Reserve Acquisition Corp. Unit Trades Flat - GEX Level - careplusvn.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	73 (M)
Shares Float	107 (M)
Held by Insiders	10.9 (%)
Held by Institutions	42.2 (%)
Shares Short	3,150 (K)
Shares Short P.Month	3,260 (K)

EPS	-4.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.05
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-44.4 %
Return on Equity (ttm)	-87 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-2.29
Qtrly Earnings Growth	0 %
Operating Cash Flow	-141 (M)
Levered Free Cash Flow	-82 (M)

PE Ratio	-3.05
PEG Ratio	0
Price to Book value	247.39
Price to Sales	0
Price to Cash Flow	-6.42

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.